{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:39:09Z","timestamp":1794299949202,"version":"4.9.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018635","name":"Thousand Young Talents Program of China","doi-asserted-by":"publisher","award":["QNQR-2021-02"],"award-info":[{"award-number":["QNQR-2021-02"]}],"id":[{"id":"10.13039\/501100018635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304291"],"award-info":[{"award-number":["82304291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371180"],"award-info":[{"award-number":["82371180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901163"],"award-info":[{"award-number":["81901163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173716"],"award-info":[{"award-number":["82173716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118389","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:03:27Z","timestamp":1763827407000},"page":"118389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3\u03b2 inhibitors with effective In vivo anti-AD activity"],"prefix":"10.1016","volume":"303","author":[{"given":"Wenjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118389_bib1","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.apsb.2021.06.017","article-title":"TRIB3\u2012GSK-3\u03b2 interaction promotes lung fibrosis and serves as a potential therapeutic target","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118389_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118389_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100779","article-title":"GSK3\u03b2 as a novel promising target to overcome chemoresistance in pancreatic cancer","volume":"58","author":"Pecoraro","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejmech.2025.118389_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118389_bib5","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in alzheimer's disease - a potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2025.118389_bib6","article-title":"Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation","volume":"2011","author":"Hanger","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2025.118389_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.018","article-title":"Pivotal role of glycogen synthase kinase-3: a therapeutic target for alzheimer's disease","volume":"107","author":"Maqbool","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib8","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118389_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118389_bib10","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase Kinase-3\u03b2 by tideglusib","volume":"287","author":"Dom\u00ednguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129932","article-title":"Design, synthesis and biological evaluation of thieno[3,2-c]pyrazol-urea derivatives as potent glycogen synthase kinase 3\u03b2 inhibitors based on the DFG-out conformation","volume":"112","author":"Yan","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118389_bib13","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1021\/acs.jmedchem.3c00364","article-title":"Discovery of 2-(Anilino)pyrimidine-4-carboxamides as highly potent, selective, and orally active glycogen synthase Kinase-3 (GSK-3) inhibitors","volume":"66","author":"Hartz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib14","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.jmedchem.3c00133","article-title":"Design, structure-activity relationships, and in vivo evaluation of potent and brain-penetrant Imidazo[1,2-b]pyridazines as glycogen synthase Kinase-3\u03b2 (GSK-3\u03b2) inhibitors","volume":"66","author":"Hartz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117236","article-title":"Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3\u03b2 inhibitors for treating Alzheimer's disease","author":"Xun","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113554","article-title":"Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3\u03b2\/DYRK1A dual inhibitors for the treatment of alzheimer's disease","volume":"222","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114301","article-title":"Development of inhibitors targeting glycogen synthase kinase-3beta for human diseases: strategies to improve selectivity","volume":"236","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113889","article-title":"Discovery of PT-65 as a highly potent and selective proteolysis-targeting chimera degrader of GSK3 for treating alzheimer's disease","volume":"226","author":"Qu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.ejmech.2025.118389_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0044-100186","article-title":"GSK-3 inhibitors: a double-edged sword? \u2013 an update on tideglusib","volume":"68","author":"Mathuram","year":"2018","journal-title":"Drug Research"},{"key":"10.1016\/j.ejmech.2025.118389_bib21","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1002\/anie.201603797","article-title":"Discovery of a highly selective glycogen synthase Kinase\u20103 inhibitor (PF\u201004802367) that modulates tau phosphorylation in the brain: translation for PET neuroimaging","volume":"55","author":"Liang","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118389_bib22","doi-asserted-by":"crossref","first-page":"S547","DOI":"10.3233\/JAD-179934","article-title":"The conundrum of GSK3 inhibitors: is it the dawn of a new beginning?","volume":"64","author":"Bhat","year":"2018","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2025.118389_bib23","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1021\/acs.jmedchem.3c01696","article-title":"Psychoplastogenic DYRK1A inhibitors with therapeutic effects relevant to alzheimer's disease","volume":"67","author":"Warren","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.cclet.2021.10.003","article-title":"Recent research and development of DYRK1A inhibitors","volume":"33","author":"Zhao","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118389_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106168","article-title":"Discovery of novel \u03b2-carboline-1,2,3-triazole hybrids as AChE\/GSK-3\u03b2 dual inhibitors for alzheimer's disease treatment","volume":"129","author":"Liu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300404","article-title":"Discovery of novel harmine derivatives as GSK-3\u03b2\/DYRK1A dual inhibitors for alzheimer's disease treatment","volume":"357","author":"Qiu","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118389_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114095","article-title":"Discovery of novel \u03b2-carboline derivatives as selective AChE inhibitors with GSK-3\u03b2 inhibitory property for the treatment of alzheimer's disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib28","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bmcl.2015.03.046","article-title":"Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core","volume":"25","author":"Sivaprakasam","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118389_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncomms1090","article-title":"Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A","volume":"1","author":"Ogawa","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118389_bib30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/14756366.2022.2027933","article-title":"Comparative chemical and biological hydrolytic stability of homologous esters and isosteres","volume":"37","author":"de Souza","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib31","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1002\/anie.201303207","article-title":"Profound methyl effects in drug discovery and a call for new C-H methylation reactions","volume":"52","author":"Sch\u00f6nherr","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118389_bib32","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1039\/D0CS00973C","article-title":"Installing the \"magic methyl\"- C-H methylation in synthesis","volume":"50","author":"Aynetdinova","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.118389_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jnc.12203","article-title":"AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans","volume":"125","author":"Georgievska","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.118389_bib34","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1021\/jo052631n","article-title":"NMR method for the determination of solute hydrogen bond acidity","volume":"71","author":"Abraham","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib35","doi-asserted-by":"crossref","first-page":"14594","DOI":"10.1021\/acs.jmedchem.0c01246","article-title":"Optimization of the in vivo potency of pyrazolopyrimidine MALT1 protease inhibitors by reducing metabolism and increasing potency in whole blood","volume":"63","author":"Quancard","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib36","doi-asserted-by":"crossref","first-page":"11075","DOI":"10.1021\/jo502080p","article-title":"An NMR method for the quantitative assessment of intramolecular hydrogen bonding; application to physicochemical, environmental, and biochemical properties","volume":"79","author":"Abraham","year":"2014","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118389_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd3367","article-title":"Probing the links between potency, ADMET and physicochemical parameters","volume":"10","author":"Gleeson","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118389_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109525","article-title":"An inhibitor with GSK3\u03b2 and DYRK1A dual inhibitory properties reduces tau hyperphosphorylation and ameliorates disease in models of alzheimer's disease","volume":"232","author":"Liu","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118389_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118389_bib42","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16635","article-title":"New insights into the role of GSK-3\u03b2 in the brain: from neurodegenerative disease to tumorigenesis","volume":"11","author":"Lai","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.ejmech.2025.118389_bib43","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1038\/ncomms7666","article-title":"ERK7 regulates ciliogenesis by phosphorylating the actin regulator CapZIP in cooperation with dishevelled","volume":"6","author":"Miyatake","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118389_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bmc.2010.11.041","article-title":"Synthesis and evaluation of \u03b2-carboline derivatives as potential monoamine oxidase inhibitors","volume":"19","author":"Reniers","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/cmdc.201600539","article-title":"Structure\u2010based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition","volume":"12","author":"B\u00e1lint","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118389_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s42003-020-0795-6","article-title":"An isothermal shift assay for proteome scale drug-target identification","volume":"3","author":"Ball","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.118389_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/b923848b","article-title":"Protein kinase inhibition of clinically important staurosporine analogues","volume":"27","author":"Gani","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2025.118389_bib48","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1182\/blood-2008-12-190256","article-title":"Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia","volume":"113","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.118389_bib49","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","article-title":"Sustainable drug discovery of multi-target-directed ligands for alzheimer's disease","volume":"64","author":"Rossi","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib50","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib51","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.apsb.2022.03.009","article-title":"Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development","volume":"12","author":"Lai","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118389_bib52","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12035-014-8699-4","article-title":"Molecular and cellular mechanism of Okadaic acid (OKA)-induced neurotoxicity: a novel tool for alzheimer's disease therapeutic application","volume":"50","author":"Kamat","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.118389_bib53","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1021\/acs.jmedchem.4c00483","article-title":"Discovery of ZJCK-6-46: a potent, selective, and orally available dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor for the treatment of alzheimer's disease","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/alz.054807","article-title":"Lithium chloride inhibits phosphorylation of tau protein","volume":"17","author":"Asano","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2025.118389_bib55","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1021\/acs.jmedchem.2c01887","article-title":"Silmitasertib (CX-4945), a clinically used CK2-Kinase inhibitor with additional effects on GSK3beta and DYRK1A kinases: a structural perspective","volume":"66","author":"Grygier","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118389_bib56","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"Faseb j"},{"key":"10.1016\/j.ejmech.2025.118389_bib57","article-title":"Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome","volume":"17","author":"Girirajan","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejmech.2025.118389_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: a potential target and pending issues for treatment of alzheimer's disease","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.118389_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-6606-6-27","article-title":"Neurological characterization of mice deficient in GSK3\u03b1 highlight pleiotropic physiological functions in cognition and pathological activity as tau kinase","volume":"6","author":"Maurin","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejmech.2025.118389_bib60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/prot.20931","article-title":"Effective handling of induced-fit motion in flexible docking","volume":"63","author":"Mizutani","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2025.118389_bib61","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1021\/acs.jctc.2c00371","article-title":"Induced-fit docking enables accurate free energy perturbation calculations in homology models","volume":"18","author":"Xu","year":"2022","journal-title":"J. Chem. Theory Comput."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:48:05Z","timestamp":1781326085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":61,"alternative-id":["S0223523425011547"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118389","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3\u03b2 inhibitors with effective In vivo anti-AD activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118389"}}